Literature DB >> 34362221

Comparison of Distal Radial, Proximal Radial, and Femoral Access in Patients with ST-Elevation Myocardial Infarction.

Oh-Hyun Lee1, Yongcheol Kim1, Nak-Hoon Son2, Ji Woong Roh1, Eui Im1, Deok-Kyu Cho1, Donghoon Choi1.   

Abstract

Recent studies have indicated that distal radial access (DRA) is feasible in patients undergoing percutaneous coronary intervention (PCI). The present study aimed to compare DRA, proximal radial access (PRA), and femoral access (FA) in patients with ST-elevation myocardial infarction (STEMI) undergoing PCI. Data were analyzed for 109 patients with STEMI treated via primary PCI from March 2020 to May 2021. The success rate of DRA was 83.3% (35/42), including seven cases of failed puncture (puncture failure = 5, severe radial artery spasm = 2). Primary PCI via the DRA was successful in all 35 patients. After classifying the patients requiring crossover into a separate group, the percentage of the puncture time in the door-to-wiring time was 2.7% [2.2-4.3], 3.3% [2.3-4.0], 2.6% [1.2-4.9], and 27.0% [13.5-29.3] in the DRA (n = 35), PRA (n = 24), FA (n = 26), and crossover (n = 9) groups, respectively (p < 0.01). Only two local hematomas (≤5 cm) occurred in the DRA group, while one patient in the FA group required surgical treatment and a transfusion for an access-site vascular injury. When performed by an experienced operator, DRA may represent a feasible alternative to other access routes in select patients with STEMI undergoing PCI, such as those with a high risk of bleeding.

Entities:  

Keywords:  ST-elevation myocardial infarction; bleeding; percutaneous coronary intervention; radial artery

Year:  2021        PMID: 34362221     DOI: 10.3390/jcm10153438

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  1 in total

1.  Distal Radial Artery Access for Coronary and Peripheral Procedures: A Multicenter Experience.

Authors:  Alexandru Achim; Kornél Kákonyi; Zoltán Jambrik; Ferenc Nagy; Julia Tóth; Viktor Sasi; Péter Hausinger; Attila Nemes; Albert Varga; Olivier F Bertrand; Zoltán Ruzsa
Journal:  J Clin Med       Date:  2021-12-20       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.